SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-109337
Filing Date
2024-09-25
Accepted
2024-09-25 16:08:55
Documents
6
Period of Report
2024-09-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_pyxs-special_mtg_14.htm DEF 14A 824301
2 GRAPHIC img26991058_0.jpg GRAPHIC 29935
3 GRAPHIC img26991058_1.jpg GRAPHIC 17889
4 GRAPHIC img26991058_2.jpg GRAPHIC 41024
5 GRAPHIC img26991058_3.jpg GRAPHIC 1414264
6 GRAPHIC img26991058_4.jpg GRAPHIC 189697
  Complete submission text file 0000950170-24-109337.txt   3155267
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40881 | Film No.: 241324178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)